Compliance with quality prescribing indicators in terms of their relationship to financial incentives

详细信息    查看全文

• 作者：Rocío Fernández Urrusuno…
• 关键词：Primary care ; Quality prescribing indicators ; Financial incentives
• 刊名：European Journal of Clinical Pharmacology
• 出版年：2013
• 出版时间：October 2013
• 年：2013
• 卷：69
• 期：10
• 页码：1845-1853
• 全文大小：172KB
• 参考文献：1. Jackson SHD, Mangoni AA, Batty GM (2003) Optimization of drug prescribing. British J Clin Pharmacol 57:231-36 CrossRef
  2. Aronson J (2004) Rational prescribing, appropriate prescribing. British J Clin Pharmacol 57:229-30 CrossRef
  3. Cantrill JA, Sibbad B, Buetow S (2004) Indicators of the appropriateness of long-term prescribing in general practice in the UK: consensus development, face and content validity, feasibility and reliability. Qual health Care 7:130-35
  4. Campbell SM, Braspenning J, Hutchinson A, Marshall M (2002) Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care 11:358-64 CrossRef
  5. Campbell SM, Cantrill JA, Roberts D (2002) Prescribing indicators for UK general practice: Delphi consultation study. BMJ 321:1- CrossRef
  6. Hoven JL, Haaijer-Ruskamp FM, Vander Stichele RH (2005) Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-5 May 2004). Eur J Clin Pharmacol 30:831-34 CrossRef
  7. Okechukwu I, Bennerr K, Feely J (2005) General practitioners ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database. Br J Cllin Pharmacol 62:218-24 CrossRef
  8. Wollersheim H, Hermens R, Hulscher M, Braspenning J, Ouwens M, Schouten J, Marres H, Dijkstra R, Grol R (2007) Clinical indicators: development and applications. Netherl J Med 65:15-2
  9. Barber N (1995) What constitutes good prescribing? BMJ 10:923-25 23">CrossRef
  10. Pringle M, Wilson T, Grol R (2002) Measuring “goodness-in individuals and healthcare systems. BMJ 325:704-07 CrossRef
  11. National Prescribing Service (2006) Indicators of quality prescribing in Australian general practice. February 2006. Available at: http://www.nps.org.au/__data/assets/pdf_file/0019/37351/indicators_full.pdf.
  12. Prescribing Measures and their application (2009) NHS. The information centre for health and social care. Available at: http://www.ic.nhs.uk/webfiles/Services/PSU/Prescribing%20Measures%206th%20edition.pdf.
  13. Fretheim A, Oxman AD, Havelsrud K, Treweek S, Kristoffersen D, Bjorndal A (2006) Rational prescribing in Primary Care (RaPP): a cluster randomized trial of a tailored intervention. PLOS Med 3(6):e 134. doi:10.1371/journal.pmed.0030134
  14. Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV (2007) The effect of adherence to practice guidelines in depression outcomes. Ann Intern Med 147:320-29 CrossRef
  15. Serumaga B, Ross-Degnan D, Avery AJ, Majumdar SR, Zhang F, Soumerai SB (2011) Effect of pay for performance on the management and outcomes on hypertension in the United Kingdom: interrupted time series study. BMJ 342:d108. doi:10.1136/bmj.d108 CrossRef
  16. Scott A, Sirvey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D (2011) The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.:CD008451. doi:10.1002/14651858.CD008451.pub2 .
  17. Witter S, Fretheim A, Kessy F, Lindahl AK (2012) Paying for performance to improve the delivery of health interventions in low- and middle-income countries. Cochrane Database of Systematic Reviews 2012, Issue 2. Art No: CD007899. doi:10.1002/14651858.CD007899.pub2 .
  18. Gillan SJ, Siriwardena AN, Steel N. Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework. A systematic review (2012) Ann. Fam Pract 10:461-68
  19. Rosenthal MB, Frank RG, Li Z, Epstein AM (2005) Early experience with pay for performance: from concept to practice. JAMA 294:1788-793 CrossRef
  20. Campbell SM, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M (2007) Quality of primary care in England with the introduction of pay for performance. N Engl J Med 357:181-90 CrossRef
  21. Fleetcroft R, Steel N, Cookson R, Walker S, Howe A (2012) Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis. BMC Health Serv Res 12:94 CrossRef
  22. Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M (2009) Effects of pay for performance on the quality of primary care in England. N Engl J Med 361:368-78 CrossRef
  23. Campbell SM, McDonald R, Lester H (2008) The experience of pay for performance in English family practice: a qualitative study. Ann Fam Med 6:228-34 CrossRef
  24. Lester H, Schmittdiel J, Selby J, Fireman B, Campbell S, Lee J, Whippy A, Madving P (2010) The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ 340:c1898 CrossRef
  25. Petersen L, Woodard L, Urech T, Draw C, Sookanan S (2006) Does pay for performance improve the quality of health care? Ann Intern Med 145:265-72 CrossRef
  26. Servicio Andaluz de Salud. Subdirección de Farmacia y Prestaciones farmacéuticas (2007) Continuous improvement of quality of prescribing. Targets for drugs selection. Contract Program 2007. Distrito Sanitario Aljarafe, Seville (ed) [in Spanish].
  27. Consejería de Salud Junta de Andalucía. Procesos Asistenciales Integrados. Available at: http://www.juntadeandalucia.es/salud/sites/csalud/contenidos/Informacion_General/p_3_p_3_procesos_asistenciales_integrados/listado_procesos?perfil=org (acceded January 2007) [in Spanish].
  28. Dirección General de Calidad e Innovación en los Servicios Sanitarios (2007) Quality prescribing indicators. Consejería de Salud y Servicios Sanitarios del Principado de Asturias, Oviedo (ed) [in Spanish].
  29. Fernandez Urrusuno R, Montero Balosa MC, Pascual de la Pisa B, Jurado Mateos S, Beltran Calvo C (2010) Developing indicators of prescribing quality for primary care paediatricians. J Pharm Health Ser Res 1:167-73 CrossRef
  30. Scoggins A, Tiessen J, Ling T, Rabinovich L (2007) Prescribing in primary care. Understanding what shapes GP’s prescribing choices and how might these be changed. RAND Corporation 2007. Available at: http://www.rand.org/pubs/technical_reports/2007/RAND_TR443.sum.pdf.
  31. Avery AJ, Dex GM, Mulvaney C, Serumaga B, Spencer R, Lester HE, Campbell SM (2011) Development of prescribing-safety indicators for GPs using the RAND appropriateness method. Bit J Gen Pract. doi:10.3399/bjgp11X588501
  32. Arnold SR, Straus SE (2005) Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003539. doi:10.1002/14651858.CD003539.pub2 .
  33. Freemantle N, Harvey E, Wolf F, Grimshaw J, Grilli R, Bero L (1997) Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 1997, Issue 2. Art. No.: CD000172. doi:10.1002/14651858.CD000172 .
  34. Forsetlund L, Bj?rndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf FM, Davis D, Odgaard-Jensen J, Oxman AD (2009) Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003030. doi:10.1002/14651858.CD003030.pub2 .
  35. Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, Graham ID, Turcotte S (2010) Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No.: CD006732. doi:10.1002/14651858.CD006732.pub2 .
  36. Andersen M (2006) Is it possible to measure prescribing quality using only prescription data? Basic Clin Pharmacol Toxicol 98:314-19 CrossRef
  37. Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM (2004) Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 59:833-40 CrossRef
  38. Shelley M, Croft P, Chapman S, Pantin C (1996) Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ 313:1124-126 CrossRef
  39. Maysey S, Steel N, Marsh R, Gilliam S, Fleetcroft R, Howe A (2008) Effects of payment for performance in primary care: qualitative interview study. J Health Serv Res Policy 13:133-39 CrossRef
  40. Rasmussen HMS, Sondergaard J, Kampmann JP, Andersen M (2005) General practitioners prefer prescribing indicators based on detailed information on individual patients: a Delphi study. Eur J Clin Pharmacol 61:237-41 CrossRef
  41. Morris CJ, Cantrill JA, Avery AJ, Howard RL (2006) Preventing drug related morbidity: a process for facilitating changes in practice. Qual Saf Health Care 15:116-21 CrossRef
  42. Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA (2004) Indicators for preventable drug morbidity: application in primary care. Qual Saf Health Care 13:181-85 CrossRef
  43. Morris CJ, Cantrill JA (2004) Preventing drug-related morbidity. The development of quality indicators. J Clin Pharm Ther 28:295-05 CrossRef
  44. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K (2011) High risk prescribing in primary care patients particularly vulnerable to adverse drugs events: cross sectional population database analysis in Scottish general practice. BMJ 342:d3514. doi:10.1136/bmj.d3514 CrossRef
  
• 作者单位：Rocío Fernández Urrusuno (1)
  Ma Carmen Montero Balosa (1)
  Pastora Pérez Pérez (2)
  Beatriz Pascual de la Pisa (3)
  
  1. Service of Pharmacy, Aljarafe-Sevilla Norte Primary Health Care Area, Distrito Sanitario Aljarafe; Avda de las Américas s/n, 41927, Mairena del Aljarafe, Seville, Spain
  2. Andalucian Patient Safety Observatory, Agency for Health Care Quality, Aljarafe Primary Health Care Area, Seville, Spain
  3. Family and Communitary Practice, Aljarafe-Sevilla Norte Primary Health Care Area, Seville, Spain
  
• ISSN：1432-1041

文摘

Objective To develop quality prescribing indicators for general practitioners (GPs) who are non-monitored and not included in pay-for-performance programs, and to determine compliance with incentivized and non-incentivized indicators. Study design Descriptive cross sectional study. Setting: Aljarafe Primary Health Care Area (Andalusian Public Health Care Service, Spain), a rural and suburban area with a population of 323,857 inhabitants. Health assistance in this area is provided by 176 GPs in 37 health centers. Prescribing indicators were developed by a multidisciplinary group using a qualitative technique based on consensus. The members of the consensus group searched for updated recommendations focused on clinical evidence. Prescribing data were obtained from the computerised pharmacy records of reimbursed drugs and clinical data from the electronic clinical databases and hospital admission records. Results Fourteen indicators based on the selection of drugs of different therapeutic groups or linked to patient′s clinical information were designed. The compliance with indicators based on the selection of drugs linked to financial incentives was higher than that of indicators not linked to financial incentives. The compliance with indicators based on clinical information varied widely. Inappropriate prescribing ranged from 7?%, in the use of long-acting beta-agonists in asthma, to 86?% in the use of drugs for the prevention of osteoporotic fractures in young women. Conclusions This study shows better compliance by GPs with indirect and incentivized quality prescribing indicators, included in pay-for-performance programs, compared with not-incentivized indicators based on the relative use of drugs and on the appropriateness prescribing.